Lv5
1060 积分 2024-12-02 加入
Survival Outcomes With or Without Risk-Reducing Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers
26分钟前
待确认
Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study
1个月前
已完结
Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer
3个月前
已完结
Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma
5个月前
已完结
Multimodality Management of Urachal Carcinoma: The M. D. Anderson Cancer Center Experience
5个月前
已完结
Evaluation of the Management of Urachal Carcinoma: A Single-Center Experience over 13 Years
5个月前
已完结
A phase 2 study of sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors (SMART) – design and rationale
5个月前
已完结
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
6个月前
已完结
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
6个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
9个月前
已完结